智通财经APP讯,复星医药(02196)公布,2025 年 4 月 25 日,公司控股子公司复星平耀与上海复健、复星高科技、复曜智港拟分别出资人民币 490 万元、10 万元、290 万元和 210 万元共同设立河南复健(暂定名,最终以登记机关核准为准)。河南复健设立后,复星平耀、上海复健、复星高科技、复曜智港将分别持有其 49%、1%、29%和 21%的财产份额。河南复健设立后,将成为公司的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.